Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Emerging variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are of clinical concern. In a cohort of 417 persons who had received the second dose of BNT162b2 (Pfizer–BioNTech) or mRNA-1273 (Moderna) vaccine at least 2 weeks previously, we identified 2 women with vaccine breakthr...

Descripción completa

Detalles Bibliográficos
Autores principales: Hacisuleyman, Ezgi, Hale, Caryn, Saito, Yuhki, Blachere, Nathalie E., Bergh, Marissa, Conlon, Erin G., Schaefer-Babajew, Dennis J., DaSilva, Justin, Muecksch, Frauke, Gaebler, Christian, Lifton, Richard, Nussenzweig, Michel C., Hatziioannou, Theodora, Bieniasz, Paul D., Darnell, Robert B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Massachusetts Medical Society 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117968/
https://www.ncbi.nlm.nih.gov/pubmed/33882219
http://dx.doi.org/10.1056/NEJMoa2105000

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117968/
https://www.ncbi.nlm.nih.gov/pubmed/33882219
http://dx.doi.org/10.1056/NEJMoa2105000

Ejemplares similares